AHR and neoplasm: The kynurenine-AhR pathway directly upregulates PD-1 expression on CD8+ T cells, while interferon gamma (IFNγ) expression from activated CD8+ T cells drives further kynurenine production from tumor repopulating cells, leading to paracrine deactivation [77].